(Total Views: 1185)
Posted On: 04/14/2019 11:49:27 AM
Post# of 2146
Let's do the Math For ELTP Shall We For Kicks!!
850 Million Shares Outstanding.
Let's call it 1 Billion Shares Outstanding for Simplicity.
Each $10 Million in profit is $.01 earnings per share.
Now assign a multiple or a PE. Current PE averages for companies are between 20--25
BUT
High Growth Companies get High PE's
ELTP will be a High Growth Company.
$10 Million in Profit.
Each $.01 in earning X PE 30, 60 = $.30 or $.60
$30 Million in Profit or $.03 X PE 30, 60 = $.90 or $1.80.
Isradipine is a $500 Million Market if it Works.
Think Isradipine can product profit of $30 Million or more for ELTP? I do.
Now the above example applies to the $4 Billion in Generic Drugs ELTP has entered.
My Conclusion --- Massive Gains Next two years and into the future with or without Isradipine.
Isradipine is Elite's FREE WILDCARD!!
Another CLUE: It Would NOT be Unreasonable for ELTP
to Get a Very High PE in Anticipation of Fast High Growth.
100+ PE Can Happen.
850 Million Shares Outstanding.
Let's call it 1 Billion Shares Outstanding for Simplicity.
Each $10 Million in profit is $.01 earnings per share.
Now assign a multiple or a PE. Current PE averages for companies are between 20--25
BUT
High Growth Companies get High PE's
ELTP will be a High Growth Company.
$10 Million in Profit.
Each $.01 in earning X PE 30, 60 = $.30 or $.60
$30 Million in Profit or $.03 X PE 30, 60 = $.90 or $1.80.
Isradipine is a $500 Million Market if it Works.
Think Isradipine can product profit of $30 Million or more for ELTP? I do.
Now the above example applies to the $4 Billion in Generic Drugs ELTP has entered.
My Conclusion --- Massive Gains Next two years and into the future with or without Isradipine.
Isradipine is Elite's FREE WILDCARD!!
Another CLUE: It Would NOT be Unreasonable for ELTP
to Get a Very High PE in Anticipation of Fast High Growth.
100+ PE Can Happen.
(1)
(0)
